Chr. Olesen Synthesis is Pharmaceuticals in Denmark that focus on Tolfenamic Acid business. Founded in 2011. They cover business area such as manufacturer, active pharmaceutical ingredient, api, advanced intermediate, control substance, semi-synthetic opioid, molecule, Buprenorphine, Codeine Phosphate, Dexamfetamine, Hydromorphone, Lisdexamfetamine, an election, Pramipexole, Risedronate, Terbinafine, Tolfenamic Acid, pharmaceutical client.
2011
( 13 years old in 2024 )
Tolfenamic Acid
-
Kanalholmen 8-12
2650 Hvidovre
Denmark
Private
manufactureractive pharmaceutical ingredientapiadvanced intermediatecontrol substancesemi-synthetic opioidmoleculeBuprenorphineCodeine PhosphateDexamfetamineHydromorphoneLisdexamfetaminean electionPramipexoleRisedronateTerbinafineTolfenamic Acidpharmaceutical client
* We use standard office opening hours in near Chr. Olesen Synthesis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Chr. Olesen Synthesis is Pharmaceuticals business from Denmark that founded in 2011 (13 years old in 2024), Chr. Olesen Synthesis business is focusing on Tolfenamic Acid.
Chr. Olesen Synthesis headquarter office and corporate office address is located in Kanalholmen 8-12 2650 Hvidovre Denmark.
Chr. Olesen Synthesis was founded in Denmark.
In 2024, Chr. Olesen Synthesis is currently focus on Tolfenamic Acid sector.
Above is snippet of Google Trends for "Tolfenamic Acid" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Chr. Olesen Synthesis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
